Sarilumab, a biologic, is sold as Kevzara. The FDA recently approved sarilumab (Kevzara) for the treatment of adults with polymyalgia rheumatica (PMR) who had an inadequate response to corticosteroids ...

• Sarilumab comes as a clear solution in a prefilled syringe of 200mg/1.14ml or 150mg/1.14ml which should be given by a subcutaneous route just under the skin. • The injection should be removed from ...

Discover comprehensive details about Sarilumab, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

PHILADELPHIA — Treatment with the interleukin-6 receptor antagonist sarilumab (Kevzara), along with a 14-week taper of glucocorticoids, proved to have significant efficacy in patients with relapsing ...

The appraisal committee considered evidence submitted by Sanofi and a review of this submission by the evidence review group (ERG). See the committee papers for full details of the evidence. Sarilumab ...

The recent FDA approval of sarilumab for the treatment of refractory polymyalgia rheumatica may have a significant and lasting impact on the use of long-term steroids for that condition. The phase 3, ...

Please provide your email address to receive an email when new articles are posted on . “If providers treating PMR are having difficulty tapering people off steroids without concomitant ...

Credit: Shutterstock. Patients in the sarilumab vs placebo group achieved sustained remission of polymyalgia rheumatica at higher rates. Sarilumab demonstrates significant efficacy and is safe in the ...

"In the clinical trial program, sarilumab demonstrated statistically significant, clinically-meaningful improvements in adult patients with rheumatoid arthritis by reducing signs and symptoms, ...

Sanofi’s sarilumab, approved earlier this year by both FDA and European regulators to treat severe, active rheumatoid arthritis (RA), has cleared a key access hurdle after receiving a positive ...

While several vaccines have proven to be effective at preventing the spread of COVID-19, scientists are still trying to find a good treatment against the coronavirus if you do happen to become very ...

The committee concluded that sarilumab plus methotrexate is more clinically effective than placebo plus methotrexate, and that sarilumab alone is more clinically effective than adalimumab alone for ...